Intravenously delivered mesenchymal stem cells prevent microvascular obstruction formation after myocardial ischemia/reperfusion injury

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Basic Research in Cardiology

• Publication date

  2020-05-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00395-020-0800-8PMID 32451935
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesenchymal Stem Cells Beyond Regenerative Medicine

  2020cited by this paper
• Optimized Treatment of ST-Elevation Myocardial Infarction.

  2019cited by this paper
• Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization

  2019cited by this paper
• Index of Microcirculatory Resistance as a Tool to Characterize Microvascular Obstruction and to Predict Infarct Size Regression in Patients With STEMI Undergoing Primary PCI.

  2019cited by this paper
• NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

  2019cited by this paper
• Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

  2019cited by this paper
• Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials

  2019cited by this paper
• Coronary microvascular obstruction: the new frontier in cardioprotection

  2019cited by this paper
• Reflection and observation: cell-based screening failing to detect HBV in HUMSCs derived from HBV-infected mothers underscores the importance of more stringent donor eligibility to reduce risk of transmission of infectious diseases for stem cell-based medical products

  2018cited by this paper
• Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis

  2018cited by this paper
• Coronary microembolization and microvascular dysfunction.

  2018cited by this paper
• Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy

  2017cited by this paper
• Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction: A Study of the Collaborative Registry on CMR in STEMI.

  2017cited by this paper
• Cytological character of mini pig mesenchymal stromal cells from various tissues and the attempt of cell sheet formation

  2017cited by this paper
• Mesenchymal stem cells for the management of rheumatoid arthritis: immune modulation, repair or both?

  2017cited by this paper
• The Coronary Circulation as a Target of Cardioprotection.

  2016cited by this paper
• Myocardial Hemorrhage After Acute Reperfused ST-Segment–Elevation Myocardial Infarction

  2016cited by this paper
• The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

  2016cited by this paper
• Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis.

  2016cited by this paper
• Long-Term Outcome of Combined (Percutaneous Intramyocardial and Intracoronary) Application of Autologous Bone Marrow Mononuclear Cells Post Myocardial Infarction: The 5-Year MYSTAR Study

  2016cited by this paper
• Intracoronary Transplantation of Mesenchymal Stem Cells with Overexpressed Integrin-Linked Kinase Improves Cardiac Function in Porcine Myocardial Infarction

  2016cited by this paper
• Randomized, double-blind, phase I/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction.

  2015cited by this paper
• Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials.

  2015cited by this paper
• Anti‐Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study

  2015cited by this paper
• Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction

  2014cited by this paper
• Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis.

  2014cited by this paper
• Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study

  2014cited by this paper
• Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

  2014cited by this paper
• Cardiac stem cell therapy to modulate inflammation upon myocardial infarction.

  2013cited by this paper
• Mesenchymal Stem Cell Therapy for Cardiac Inflammation: Immunomodulatory Properties and the Influence of Toll-Like Receptors

  2013cited by this paper
• Monocyte-Directed RNAi Targeting CCR2 Improves Infarct Healing in Atherosclerosis-Prone Mice

  2013cited by this paper
• Late microvascular obstruction after acute myocardial infarction: relation with cardiac and inflammatory markers.

  2012cited by this paper
• Therapeutic siRNA silencing in inflammatory monocytes

  2011cited by this paper
• Microvascular obstruction: underlying pathophysiology and clinical diagnosis.

  2010cited by this paper
• A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

  2009cited by this paper
• Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction

  2008cited by this paper
• Glucocorticoid Treatment Prevents Progressive Myocardial Dysfunction Resulting From Experimental Coronary Microembolization

  2004cited by this paper
• Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution

  2003cited by this paper
• Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

  2002cited by this paper
• Basic Research in Cardiology

  1994cited by this paper

• Evidence and perspectives on miRNA, circRNA, and lncRNA in myocardial ischemia-reperfusion injury: a bibliometric study

  2025cites this paper
• HIF-1α modulates β-catenin pathway to enhance the survival and angiogenesis of PBMSCs under hypoxia environment

  2025cites this paper
• Attenuation of myocardial ischemia–reperfusion injury in mice through CD80/86 deficiency: improved microvascular obstruction via reduced macrophage and T lymphocyte infiltration

  2025cites this paper
• Immune in myocardial ischemia/reperfusion injury: potential mechanisms and therapeutic strategies

  2025cites this paper
• Exosomes derived from human umbilical cord mesenchymal stem cells can reverse ventricular remodeling and improve long-term cardiac function after acute myocardial infarction.

  2025cites this paper
• Cardiac preservation using ex vivo organ perfusion: new therapies for the treatment of heart failure by harnessing the power of growth factors using BMP mimetics like THR-184

  2025cites this paper
• Cardiac rehabilitation in porcine models: Advances in therapeutic strategies for ischemic heart disease

  2025cites this paper
• Subaxillary implantation of mesenchymal stem cell spheroids is a novel therapy for myocardial ischemia reperfusion injury

  2025cites this paper
• Growth differentiation factor-15 as a negative predictor for microvascular obstruction in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention

  2024cites this paper
• Review of Gene Therapy on Myocardial Ischemia-Reperfusion Injury Treatment

  2024cites this paper
• Intravenous infusions of mesenchymal stromal cells have cumulative beneficial effects in a porcine model of chronic ischaemic cardiomyopathy

  2024cites this paper
• Advances in preclinical surgical therapy of cardiovascular diseases

  2024cites this paper
• Recent advances in mesenchymal stem cell therapy for myocardial infarction

  2024cites this paper
• Stem cell-based therapy in cardiac repair after myocardial infarction: Promise, challenges, and future directions.

  2024cites this paper
• Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing.

  2023cites this paper
• Mesenchymal Stem Cell-Derived Exosomal Noncoding RNAs as Alternative Treatments for Myocardial Ischemia-Reperfusion Injury: Current Status and Future Perspectives

  2023cites this paper
• Translational large animal model of coronary microvascular embolism: characterization by serial cardiac magnetic resonance and histopathology

  2023cites this paper
• Iron oxide nanoparticles: A promising approach for diagnosis and treatment of cardiovascular diseases

  2023cites this paper
• Downregulation of ALKBH5 rejuvenates aged human mesenchymal stem cells and enhances their therapeutic efficacy in myocardial infarction

  2023cites this paper
• Interleukin-37 contributes to endometrial regenerative cell-mediated immunotherapeutic effect on chronic allograft vasculopathy.

  2023cites this paper
• Melatonin Attenuates Ischemia/Reperfusion-Induced Oxidative Stress by Activating Mitochondrial Fusion in Cardiomyocytes

  2022cites this paper
• Inflammation in myocardial infarction: roles of mesenchymal stem cells and their secretome

  2022cites this paper
• Infusion of two-dose mesenchymal stem cells is more effective than a single dose in a dilated cardiomyopathy rat model by upregulating indoleamine 2,3-dioxygenase expression

  2022cites this paper
• Peli1 contributes to myocardial ischemia/reperfusion injury by impairing autophagy flux via its E3 ligase mediated ubiquitination of P62.

  2022cites this paper
• Modified Exosomes: a Good Transporter for miRNAs within Stem Cells to Treat Ischemic Heart Disease

  2022cites this paper
• Irisin Promotes Cardiac Homing of Intravenously Delivered MSCs and Protects against Ischemic Heart Injury

  2022cites this paper
• ZBTB20 Positively Regulates Oxidative Stress, Mitochondrial Fission, and Inflammatory Responses of ox-LDL-Induced Macrophages in Atherosclerosis

  2021cites this paper
• Sevoflurane preconditioning promotes mesenchymal stem cells to relieve myocardial ischemia/reperfusion injury via TRPC6-induced angiogenesis

  2021cites this paper
• PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion Injury

  2021cites this paper
• Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases

  2021influential citation
• Protective Effect of Optic Atrophy 1 on Cardiomyocyte Oxidative Stress: Roles of Mitophagy, Mitochondrial Fission, and MAPK/ERK Signaling

  2021cites this paper
• Molecular Perspectives of Mitophagy in Myocardial Stress: Pathophysiology and Therapeutic Targets

  2021cites this paper
• Melatonin Attenuates ox-LDL-Induced Endothelial Dysfunction by Reducing ER Stress and Inhibiting JNK/Mff Signaling

  2021cites this paper
• Bevacizumab-Induced Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and ERK Inactivation Contribute to Cardiotoxicity

  2021cites this paper
• miRNA-126-3p carried by human umbilical cord mesenchymal stem cell enhances endothelial function through exosome-mediated mechanisms in vitro and attenuates vein graft neointimal formation in vivo

  2020cites this paper